+13.1%
GSK vs PTEN
+79.8%
-66.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PTEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | -9.4% | +14.4% | +4.2% |
| 7D | +4.9% | -15.5% | +20.4% | +3.6% |
| 30D | +9.9% | -7.8% | +17.7% | +9.4% |
| 3M | +0.2% | +6.4% | -6.2% | +0.8% |
| 6M | +2.3% | -11.9% | +14.2% | +1.8% |
| YTD | +7.1% | +79.4% | -72.3% | +1.9% |
| 1Y | +13.1% | +84.9% | -71.8% | +6.8% |
| All | +13.1% | +79.8% | -66.7% | +6.8% |
Cumulative growth
Daily Returns
Daily percentage return beside PTEN.
Daily Out/Under-Performance
Portfolio return minus PTEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PTEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PTEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling